Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

CLINICAL THERAPEUTICS

2025; Oct 14:S0149-2918(25)00310-8

Pharmacokinetics and Pharmacodynamics of a Novel Formulation of Furosemide Administered as a Single Subcutaneous Injection

view publication

CLINICAL PHARMACOKINETICS

2025; 64(6): 899–908.

An Adult Population Pharmacokinetic Model to Simulate Subcutaneous Administration of a Fixed Dose of Furosemide in Adolescents with Heart Failure and Volume Overload.

view publication

DIABETES CARE

2025; 48(3); 353-360

A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes

view publication

Diabetes Therapy

2025

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion

view publication

DIABETES CARE

2024;47(9):1682-1687

A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery

view publication

MEDICAL DEVICES: EVIDENCE AND RESEARCH

2024; June 24;17: 229-235.

Human Factors Validation of a Wearable, On-Body Infusor for Subcutaneous Administration of Furosemide.

view publication

EUROPEAN JOURNAL HEART FAILURE

2024; 27(2): 347-352.

Diuretic efficiency of a single dose of subcutaneous versus oral furosemide after heart failure hospitalization across diuretic resistance strata: A pilot randomized controlled trial.

view publication

JACC HEART FAILURE

2024; 12(11): 1830-1841.

Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF).

view publication

CLINICOECONOMICS AND OUTCOMES RESEARCH

2023; Sep 29;15: 721-731.

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations

view publication

FUTURE CARDIOLOGY

2023; 19(8): 385-396.

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.

view publication

DIABETES THERAPY

2023; 14(3): 611-617

Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes

view publication

STRUCTURAL HEART

2022; Aug 7; 6(4): 100076.

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion.

view publication